Nature Medicine Publishes Interim Results from Gritstone bio ' s Phase 1/2 Study of " Off-the-Shelf " Neoantigen Vaccine Platform (SLATE)

Discovery of a novel immunodominance hierarchy of tumor neoantigens (including KRAS) enabled the development of a more potent, KRAS-specific vaccine candidate (SLATE-KRAS) being studied by Steven A. Rosenberg of the National Cancer Institute (NCI) -- -- Publication underscores the important role…#discovery #kras #stevenarosenberg #nci #emeryville #gritstonebioinc #naturemedicine #gritstone #phase1 #phase2
Source: Reuters: Health - Category: Consumer Health News Source Type: news